UK medtech free sale cert changes near as MHRA gets oversight
This article was originally published in Clinica
Executive Summary
The Department of Health in the UK is planning to transfer the oversight of the system of issuing certificates of free sale (CFS) to medical device companies to the national medicines and healthcare products regulator, the MHRA, next year.